Glomerular-vascular syndrome

出自KMU Wiki

在2018年3月13日 (二) 17:37所做的修訂版本 (編輯) Guhjy (對話 | 貢獻) (新頁面: *Risk factors **Aging, obesity, insulin resistance, smoking, hypertension, hyperlipidemia **Apolipoprotein E gene polymorphism ***Lipoprotein glomerulopathy *CKD patients with GFR<60 mL/m...) ←上一個		當前修訂版本 (2018年3月28日 (三) 13:20) (編輯) (撤銷) Guhjy (對話 | 貢獻)
(3個中途的修訂版本沒有顯示。)
第1行：		第1行：
-	*Risk factors	+	*Atherosclerotic nephropathy
-	**Aging, obesity, insulin resistance, smoking, hypertension, hyperlipidemia	+	**Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic nephrosclerosis, cardiovascular diseases
-	**Apolipoprotein E gene polymorphism	+	**ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)
-	***Lipoprotein glomerulopathy	+	*[[“Hypertensive” nephrosclerosis]]
-	*CKD patients with GFR<60 mL/min have more cardiovascular events and hospitalizations than those with higher filtration rates	+	*[[Cholesterol emboli (atheroembolic renal disease)]]
-	*Approximately 10% of glomeruli are normally sclerotic by age 40, rising to 20% by age 60 and 30% by age 80	+	*[[Sickle cell disease]]
		+	*[[Thrombotic microangiopathies]]
		+	*[[Antiphospholipid syndrome]]
		+	*[[ANCA vasculitis]]
		+	*[[Henoch-Shönlein purpura]]
		+	*[[Cryoglobulinemia]]
		+	*[[Amyloidosis]]

---

當前修訂版本

• Atherosclerotic nephropathy
  • Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic nephrosclerosis, cardiovascular diseases
  • ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)
• “Hypertensive” nephrosclerosis
• Cholesterol emboli (atheroembolic renal disease)
• Sickle cell disease
• Thrombotic microangiopathies
• Antiphospholipid syndrome
• ANCA vasculitis
• Henoch-Shönlein purpura
• Cryoglobulinemia
• Amyloidosis